Thermo Fisher Scientific (Massachusetts, USA) will acquire Life Technologies Corporation (California, USA) under the terms of a definitive agreement signed earlier this week.
Thermo Fisher Scientific (Massachusetts, USA) will acquire Life Technologies Corporation (California, USA) under the terms of a definitive agreement signed earlier this week.
The deal is estimated to be $76.00 a share at a total cost of $13.6 billion. The transaction was reportedly approved by both of the company’s board of directors, according to a press release.
Life Technologies is a global biotechnology company, and is recognized as a leading player in the development of sequencing technology. The acquisition will place Thermo Fisher as a key competitor in the development of advanced genetic testing, the potential key to personalized medicine.
“We are extremely excited about this transaction because it creates the ultimate partner for our customers and significant value for our shareholders,” said Marc N. Casper, President and CEO of Thermo Fisher Scientific.
Gregory T. Lucier, Chairman and CEO of Life Technologies, commented, “This transaction brings together two companies intent on accelerating innovation for our customers and achieving greater success in a highly competitive global industry.”
Lucier added: “This combination delivers immediate and significant cash value to our stockholders and represents a successful conclusion to the board’s strategic review to enhance stockholder value and develop an even stronger future for Life Technologies.”
For more information please visit:
www.lifetechnologies.com
or
www.thermoscientific.com
Inside the Laboratory: The Gionfriddo Group at the University at Buffalo
March 28th 2024In this edition of “Inside the Laboratory,” Emanuela Gionfriddo, PhD, an associate professor of chemistry at the University at Buffalo, discusses her group’s current research endeavors, including using solid-phase microextraction (SPME) coupled to liquid chromatography (LC) and gas chromatography (GC) to further understand the chemical relationship between environmental exposure and disease and elucidate micropollutants fate in the environment and biological systems.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.